Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a minor version update with no changes to trial data or user-facing content. This is a behind-the-scenes update to the page rendering.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedUpdates the ClinicalTrials.gov page’s revision/version indicator from v3.5.2 to v3.5.3, reflecting a site maintenance or display update rather than any change to the trial content or results.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded the MeSH term 'Clear cell carcinoma of kidney' and a 'Genetic and Rare Diseases Information Center' resource reference under Resources.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2 label.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.